Abstract
Lung transplantation remains the only cure for selected patients with advanced irreversible lung diseases. More than 4000 lung transplants are performed worldwide annually. In the last two decades, significant advances have been made in this arena, the most impactful being a modest but improved survival of the recipients. Unfortunately majority of recipients still succumb to chronic lung allograft dysfunction (CLAD), and it remains the most common cause of death after the first year of transplantation. Below is a concise review of the current definition of CLAD, including the various phenotypes, and a brief discussion of the tools available for its diagnosis and management.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 318-325 |
| Number of pages | 8 |
| Journal | Indian Journal of Thoracic and Cardiovascular Surgery |
| Volume | 38 |
| DOIs | |
| State | Published - Jul 2022 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2021, Indian Association of Cardiovascular-Thoracic Surgeons.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Chronic lung allograft dysfunction
- Chronic rejection
- Lung transplantation
PubMed: MeSH publication types
- Journal Article
- Review
Fingerprint
Dive into the research topics of 'Chronic lung allograft dysfunction'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS